We are live on ! Find out more
SP

Syncona Portfolio Portfolio holdings

AUM $25.7M
1-Year Est. Return 13.32%
This Fund
S&P 500
This Quarter Est. Return
+3.81%
1 Year Est. Return
+13.32%
3 Year Est. Return
+8.47%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$67.1M
AUM Growth
+$776K
Cap. Flow
-$4
Cap. Flow %
-0%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
FRLN
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
+$4

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AUTL
1
Autolus Therapeutics
AUTL
$386M
$49.7M 74.11%
21,346,829
– –
ACHL
2
DELISTED
Achilles Therapeutics
ACHL
$10.1M 15.03%
11,086,909
– –
FRLN
3
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
$6.22M 9.26%
1,466,507
-1
-0% -$4
ADAP
4
DELISTED
Adaptimmune Therapeutics
ADAP
$1.07M 1.6%
1,377,294
– –

Similar funds

BAM
BTS Asset Management Lincoln, Massachusetts $25.9M AUM 2.16% 1-Year Est. Return
FCC
Florin Court Capital London, United Kingdom $26.5M AUM 34.2% 1-Year Est. Return
BWG
Berry Wealth Group Granbury, Texas $26.8M AUM 31.56% 1-Year Est. Return
LTM
Lotus Technology Management Orlando, Florida $27M AUM
TCM
Teza Capital Management Chicago, Illinois $27.3M AUM 29.09% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.5M AUM
BCM
Bancreek Capital Management Santa Monica, California $23.1M AUM 4.01% 1-Year Est. Return
BCM
BCK Capital Management Stamford, Connecticut $23M AUM 33.03% 1-Year Est. Return

Syncona Portfolio's Q3 2023 Portfolio in Review

As of Q3 2023, Syncona Portfolio held 4 positions worth $67.1M, up 1.2% from $66.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 0%. Syncona Portfolio opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Syncona Portfolio's biggest Q3 2023 reduction was Freeline Therapeutics Holdings plc American Depositary Shares, cutting an estimated $4.
  • Syncona Portfolio's ten largest holdings make up 100% of its $67.1M portfolio in Q3 2023.
  • Syncona Portfolio opened 0 new positions and closed 0 in Q3 2023.
  • Syncona Portfolio's portfolio value rose 1.2% quarter-over-quarter to $67.1M.

Based on Syncona Portfolio's 13F filing for Q3 2023, filed 1 Nov 2023.